Amgen Beats But Maintains Outlook
Amgen (NASDAQ:AMGN) reported first quarter earnings per share of $1.59, 16 cents above the Zacks Consensus Estimate and 20.5% above the year-ago period. A lower tax rate, lower share count and higher revenues contributed to the year-over-year increase in earnings. Total revenue increased 9.2% to $4,048 million in the first quarter of 2012. Revenues comfortably [...]
Amgen (NASDAQ:AMGN) reported first quarter earnings per share of $1.59, 16 cents above the Zacks Consensus Estimate and 20.5% above the year-ago period. A lower tax rate, lower share count and higher revenues contributed to the year-over-year increase in earnings.
Total revenue increased 9.2% to $4,048 million in the first quarter of 2012. Revenues comfortably surpassed the Zacks Consensus Estimate of $3,936 million. However, revenues included a $50 million payment received from AstraZeneca (NYSE:AZN) … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards